30 Participants Needed

Mind and Body Approach for MCI

BW
Overseen ByBonnie Wong, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The aim of this application is to develop a computer-based multimodal mind and body approach (CMMBA) for mild cognitive impairment (MCI). This product will provide a new, cost-effective and easily accessible treatment option for MCI and potentially other age-related dementia.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Computer-based Multimodal Mind and Body Approach (cbMMBA) for mild cognitive impairment (MCI)?

Research shows that mind-body therapies, which include meditation and cognitive training, can improve brain function and reduce stress in older adults with mild cognitive impairment. These therapies are considered effective and minimally invasive for managing cognitive health in older adults.12345

Is the Mind and Body Approach for MCI safe for humans?

The research on mind-body interventions, including meditation and acupuncture, suggests they are generally safe for older adults with mild cognitive impairment, with no significant safety concerns reported in the studies.13678

How does the Computer-based Multimodal Mind and Body Approach (cbMMBA) treatment differ from other treatments for mild cognitive impairment (MCI)?

The cbMMBA treatment is unique because it combines multiple mind-body interventions, such as meditation and cognitive exercises, to enhance brain function and reduce stress, which are not typically addressed together in standard treatments for MCI. This approach aims to improve brain connectivity and reduce risk factors like stress and depression, potentially delaying the progression to Alzheimer's disease.136910

Eligibility Criteria

This trial is for individuals with Mild Cognitive Impairment (MCI) who are not demented, have cognitive issues confirmed by tests like MoCA, can independently manage daily activities, and have noticed or been told they're experiencing a decline in memory or thinking skills. It's not for those with severe sensory impairments, conditions preventing exercise or acupressure, major neurological disorders, psychiatric diseases affecting cognition, or prior experience with similar mind-body techniques.

Inclusion Criteria

Not demented
Cognitive impairment is confirmed by objective cognitive measures (Montreal Cognitive Assessment (MoCA) and neuropsychological testing), where objective cognitive impairment is defined as poor performance in one or more cognitive measures suggesting deficit in one or more cognitive domains
I can perform daily activities on my own.
See 1 more

Exclusion Criteria

I have severe problems with my vision or hearing.
I have a condition that prevents me from doing certain physical activities or receiving acupressure.
I have not had any major neurological, psychiatric, or other medical conditions that could affect my thinking.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a computer-based multimodal mind and body approach (cbMMBA) including BDJ, acupressure, and relaxation techniques, or a standard cognitive training using paper puzzles

12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Computer-based Multimodal Mind and Body Approach (cbMMBA)
Trial Overview The study is testing a new computer-based multimodal mind and body approach (cbMMBA) against standard cognitive training to see if it can help people with MCI. The cbMMBA includes exercises that engage both the mind and body potentially offering an accessible treatment option for age-related cognitive decline.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: A computer-based multimodal mind and body approach (cbMMBA)Experimental Treatment1 Intervention
cbMMBA will include three modules: BDJ (module 1), acupressure (module 2), and relaxation techniques including deep breathing, guided imagery, and progressive muscle relaxation
Group II: a standard cognitive trainingActive Control1 Intervention
The program uses paper puzzles (Sudoku, crosswords, word-search, etc.) to engage subjects

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Findings from Research

Mind-body interventions, including mindfulness, yoga, and Tai Chi, have been shown to improve cognitive function and daily activities in older adults with mild cognitive impairment (MCI), based on a review of nine studies.
These interventions also contributed to a moderate reduction in fall risk, depression, and stress, and may lower the risk of dementia over one year, although the studies had limitations such as small sample sizes and lack of long-term follow-up.
Impact of mind-body interventions in older adults with mild cognitive impairment: a systematic review.Farhang, M., Miranda-Castillo, C., Rubio, M., et al.[2020]
Cognitively oriented treatments (COTs) for individuals with mild cognitive impairment (MCI) have been shown to improve cognitive performance, as evidenced by a review of 7 studies that utilized fMRI to assess changes before and after treatment.
The improvements in cognition are linked to both compensatory mechanisms (engaging alternative brain regions) and restorative mechanisms (reengaging typical brain regions), indicating that COTs can positively influence brain function in MCI patients.
Neurophysiologic and Cognitive Changes Arising from Cognitive Training Interventions in Persons with Mild Cognitive Impairment: A Systematic Review.Miotto, EC., Batista, AX., Simon, SS., et al.[2020]
In a pilot study involving 14 adults with mild cognitive impairment (MCI), those who participated in Mindfulness Based Stress Reduction (MBSR) showed improved connectivity in brain regions associated with MCI and Alzheimer's Disease compared to those receiving usual care.
MBSR participants also exhibited trends towards reduced hippocampal atrophy, suggesting that this meditation technique may help protect against brain changes linked to cognitive decline.
Meditation's impact on default mode network and hippocampus in mild cognitive impairment: a pilot study.Wells, RE., Yeh, GY., Kerr, CE., et al.[2022]

References

Impact of mind-body interventions in older adults with mild cognitive impairment: a systematic review. [2020]
Neurophysiologic and Cognitive Changes Arising from Cognitive Training Interventions in Persons with Mild Cognitive Impairment: A Systematic Review. [2020]
Meditation's impact on default mode network and hippocampus in mild cognitive impairment: a pilot study. [2022]
Association of nonpharmacological interventions for cognitive function in older adults with mild cognitive impairment: a systematic review and network meta-analysis. [2023]
Mind-Body Therapies for Late-Life Mental and Cognitive Health. [2019]
Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: an interdisciplinary perspective. [2017]
Multivariate granger causality analysis of acupuncture effects in mild cognitive impairment patients: an FMRI study. [2021]
[Therapeutic efficacy assessment of Chinese medicine on mild cognitive impairment]. [2016]
Self-perception and anticipated efficacy of the anti-dementia multimodal program in 100 older adults with mild cognitive impairment. [2023]
The Effectiveness of a Multimodal Brain Empowerment Program in Mild Cognitive Impairment: A Single-Blind, Quasi-Randomized Experimental Study. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity